Target Name: KRTAP10-4
NCBI ID: G386672
Review Report on KRTAP10-4 Target / Biomarker Content of Review Report on KRTAP10-4 Target / Biomarker
KRTAP10-4
Other Name(s): High sulfur keratin-associated protein 10.4 | Keratin-associated protein 10-4 | KRTAP10.4 | Keratin-associated protein 18-4 | keratin-associated protein 18.4 | KAP10.4 | Keratin-associated protein 10.4 | KRTAP18-4 | KRTAP18.4 | KR104_HUMAN | Keratin-associated protein 18.4 | high sulfur keratin-associated protein 10.4 | keratin associated protein 10-4 | KAP18-4 | Keratin associated protein 10-4

KRTAP10-4: A Potential Drug Target and Biomarker

Keratin is a protein that is found in the hair, nails, and skin. It is a complex protein that plays a vital role in the structure and function of these tissues. One of the proteins that is associated with keratin is KRTAP10-4.

KRTAP10-4 is a protein that is expressed in high concentrations in the scalp and other hair-producing areas. It is also found in the skin and nail appendages. KRTAP10-4 has been shown to be involved in a number of important biological processes, including cell signaling, tissue repair, and inflammation.

One of the potential reasons why KRTAP10-4 is being targeted as a drug target is its role in the development of certain types of cancer. For example, studies have shown that KRTAP10-4 is often overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting KRTAP10-4 may be a promising strategy for the development of new treatments for these cancers.

In addition to its potential as a cancer drug target, KRTAP10-4 has also been shown to be involved in a number of other biological processes that could make it an attractive biomarker. For example, KRTAP10-4 has been shown to be involved in the regulation of cell signaling pathways that are important for a variety of biological processes, including cell growth, differentiation, and inflammation. It has also been shown to play a role in tissue repair and regeneration, which could make it an attractive biomarker for the treatment of certain types of injuries and diseases.

Another potential use for KRTAP10-4 as a biomarker is its role in the regulation of inflammation. KRTAP10-4 has been shown to play a role in the regulation of inflammatory responses, which could make it an attractive biomarker for the development of certain types of inflammation-related diseases.

In addition to its potential as a cancer drug target and biomarker, KRTAP10-4 is also of interest to researchers as a potential therapeutic agent. Studies have shown that KRTAP10-4 has been shown to have a number of potential therapeutic benefits, including its ability to stimulate the production of new hair cells and its ability to stimulate the growth of certain types of tissue.

Overall, KRTAP10-4 is a protein that has a number of interesting biological properties and functions. As a result, it is an attractive target for the development of new treatments for a variety of diseases. While further research is needed to fully understand the role of KRTAP10-4 in these biological processes, its potential as a cancer drug target and biomarker makes it a valuable addition to the growing list of proteins that are being targeted by researchers and pharmaceutical companies.

Protein Name: Keratin Associated Protein 10-4

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP10-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP10-4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRTAP10-5 | KRTAP10-6 | KRTAP10-7 | KRTAP10-8 | KRTAP10-9 | KRTAP11-1 | KRTAP12-1 | KRTAP12-2 | KRTAP12-3 | KRTAP12-4 | KRTAP13-1 | KRTAP13-2 | KRTAP13-3 | KRTAP13-4 | KRTAP15-1 | KRTAP16-1 | KRTAP17-1 | KRTAP19-1 | KRTAP19-2 | KRTAP19-3 | KRTAP19-4 | KRTAP19-5 | KRTAP19-6 | KRTAP19-7 | KRTAP19-8 | KRTAP2-1 | KRTAP2-2 | KRTAP2-3 | KRTAP2-4 | KRTAP20-1 | KRTAP20-2 | KRTAP20-3 | KRTAP20-4 | KRTAP21-1 | KRTAP21-2 | KRTAP21-3 | KRTAP22-1 | KRTAP22-2 | KRTAP23-1 | KRTAP25-1 | KRTAP26-1 | KRTAP27-1 | KRTAP29-1 | KRTAP3-1 | KRTAP3-2 | KRTAP3-3 | KRTAP4-1 | KRTAP4-11 | KRTAP4-12 | KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6 | KRTAP4-7 | KRTAP4-8 | KRTAP4-9 | KRTAP5-1 | KRTAP5-10 | KRTAP5-11 | KRTAP5-14P | KRTAP5-2 | KRTAP5-3 | KRTAP5-4 | KRTAP5-5 | KRTAP5-7 | KRTAP5-8 | KRTAP5-9 | KRTAP5-AS1 | KRTAP6-1 | KRTAP6-2 | KRTAP6-3 | KRTAP7-1 | KRTAP8-1 | KRTAP9-1 | KRTAP9-2 | KRTAP9-3 | KRTAP9-4 | KRTAP9-6 | KRTAP9-7 | KRTAP9-8 | KRTAP9-9 | KRTCAP2 | KRTCAP3 | KRTDAP | KSR1 | KSR1P1 | KSR2 | KTI12 | KTN1 | KTN1-AS1 | KXD1 | KY | KYAT1 | KYAT3 | KYNU | L-Type calcium channel | L-type voltage-dependent calcium channel complex | L1CAM | L1CAM-AS1